ADCT earnings
ADC Therapeutics (ADCT) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- ADCT beat EPS estimates in 11 of its last 17 reports.
ADCT earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q3 2026 | Nov 9, 2026 | -0.06 | -0.21 | 71.76% | $21.72M |
| Q3 2026 | Oct 13, 2026 | -0.16 | – | – | $21.72M |
| Q2 2026 | Aug 13, 2026 | -0.11 | -0.22 | 49.07% | $19.25M |
| Q1 2026 | May 4, 2026 | -0.21 | -0.19 | -10.53% | $20.85M |
| Q4 2025 | Mar 10, 2026 | -0.04 | -0.32 | 87.50% | $23.06M |
| Q3 2025 | Nov 10, 2025 | -0.30 | -0.40 | 25.00% | $16.43M |
| Q2 2025 | Aug 12, 2025 | -0.50 | -0.36 | -38.89% | $18.84M |
| Q1 2025 | May 14, 2025 | -0.36 | -0.38 | 5.26% | $23.03M |
| Q4 2024 | Mar 27, 2025 | -0.29 | -0.38 | 23.68% | $16.91M |
| Q3 2024 | Nov 7, 2024 | -0.42 | -0.36 | -16.67% | $18.46M |
| Q2 2024 | Aug 6, 2024 | -0.38 | -0.44 | 13.64% | $17.41M |
| Q1 2024 | May 6, 2024 | -0.56 | -0.56 | 0.00% | $18.05M |
| Q4 2023 | Mar 13, 2024 | -1.03 | -0.47 | -119.15% | $16.79M |
| Q3 2023 | Nov 7, 2023 | -0.58 | -0.61 | 4.92% | $14.49M |
| Q2 2023 | Aug 8, 2023 | -0.58 | -0.44 | -31.82% | $19.28M |
| Q1 2023 | May 9, 2023 | -0.74 | -0.80 | 7.50% | $18.99M |
| Feb 28, 2023 | -0.30 | -0.49 | 38.78% | $69.80M | |
| Nov 8, 2022 | -0.65 | -0.35 | -84.21% | $76.32M |